Analytical advances are allowing more accurate and sensitive measurements than ever before – but what if we’re not looking for the right compounds?
Charlotte Barker |
The Cloud Chasers explores the fascinating topic of electronic nicotine delivery systems (ENDS) through the lens of analytical science. In particular, I was struck by Hugo Destaillats’ comment that vaping is effectively a global toxicology experiment, which presents regulators and organizations with a difficult choice. By banning e-cigarettes, tobacco smokers could be denied a less harmful alternative. (In Japan, where nicotine-containing e-liquids are banned, smokers have turned to ‘heat-not-burn’ tobacco products, which could prove more harmful than vaping.) On the other hand, public health bodies in the UK have adopted a positive stance towards vaping, which appears (so far) to offer a less harmful alternative to tobacco smoking – a boon to those who have been unable to quit. That said, normalization of vaping could lead impressionable members of the public to underestimate the risks and see it as an entirely ‘safe’ activity. One thing is clear: there is a desperate need for more and better information on the potential health risks of chemicals of any kind being sucked into our lungs.
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.